U.S. Interventional Oncology Procedures Market (2026 - 2033)

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Segment Definitions
                        1.2.1. Technique
                        1.2.2. Procedure
                        1.2.3. Cancer Type
                        1.2.4. End Use
                        1.2.5. Country scope
                        1.2.6. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in North America
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Technique outlook
                        2.2.2. Procedure outlook
                        2.2.3. Cancer Type outlook
                        2.2.4. End Use outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Interventional Oncology Procedures Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. U.S. Interventional Oncology Procedures Market Analysis Tools
                        3.3.1. Industry Analysis – Porter’s
                            3.3.1.1. Bargaining power of suppliers
                            3.3.1.2. Bargaining power of buyers
                            3.3.1.3. Threat of substitutes
                            3.3.1.4. Threat of new entrants
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Economic landscape
                            3.3.2.3. Social landscape
                            3.3.2.4. Technological landscape
                            3.3.2.5. Environmental landscape
                            3.3.2.6. Legal landscape
Chapter 4. U.S. Interventional Oncology Procedures Market: Technique Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. Interventional Oncology Procedures Market: Technique Movement Analysis
                    4.3. U.S. Interventional Oncology Procedures Market by Technique Outlook (USD Billion)
                    4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                    4.5. Ablation Therapies
                        4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    4.6. Embolization Therapies
                        4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    4.7. Biopsy Techniques
                        4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    4.8. Targeted Therapy Delivery Systems
                        4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    4.9. Image-Guided Procedures
                        4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 5. U.S. Interventional Oncology Procedures Market: Procedure Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. Interventional Oncology Procedures Market: Procedure Movement Analysis
                    5.3. U.S. Interventional Oncology Procedures Market by Procedure Outlook (USD Billion)
                    5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                    5.5. Tumor Ablation
                        5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    5.6. Tumor Biopsy
                        5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    5.7. Vascular Interventions
                        5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    5.8. Palliative Care
                        5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 6. U.S. Interventional Oncology Procedures Market: Cancer Type Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. U.S. Interventional Oncology Procedures Market: Cancer Type Movement Analysis
                    6.3. U.S. Interventional Oncology Procedures Market by Cancer Type Outlook (USD Billion)
                    6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                    6.5. Liver Cancer
                        6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    6.6. Lung Cancer
                        6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    6.7. Kidney
                        6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    6.8. Prostate cancer
                        6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    6.9. Others
                        6.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 7. U.S. Interventional Oncology Procedures Market: End Use Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. U.S. Interventional Oncology Procedures Market: End-Use Movement Analysis
                    7.3. U.S. Interventional Oncology Procedures Market by End Use Outlook (USD Billion)
                    7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                    7.5. Hospitals
                        7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    7.6. Ambulatory Surgical Centers
                        7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    7.7. Others
                        7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 8. Competitive Landscape
                    8.1. Market Participant Categorization
                    8.2. Key Company Profiles
                        8.2.1. Medtronic
                            8.2.1.1. Company Overview
                            8.2.1.2. Financial Performance
                            8.2.1.3. Product/Service Benchmarking
                            8.2.1.4. Strategic Initiatives
                        8.2.2. Boston Scientific Corporation
                            8.2.2.1. Company Overview
                            8.2.2.2. Financial Performance
                            8.2.2.3. Product/Service Benchmarking
                            8.2.2.4. Strategic Initiatives
                        8.2.3. Johnson & Johnson MedTech
                            8.2.3.1. Company Overview
                            8.2.3.2. Financial Performance
                            8.2.3.3. Product/Service Benchmarking
                            8.2.3.4. Strategic Initiatives
                        8.2.4. Cook Medical
                            8.2.4.1. Company Overview
                            8.2.4.2. Financial Performance
                            8.2.4.3. Product/Service Benchmarking
                            8.2.4.4. Strategic Initiatives
                        8.2.5. AngioDynamics Inc.
                            8.2.5.1. Company Overview
                            8.2.5.2. Financial Performance
                            8.2.5.3. Product/Service Benchmarking
                            8.2.5.4. Strategic Initiatives
                        8.2.6. Stryker Corporation
                            8.2.6.1. Company Overview
                            8.2.6.2. Financial Performance
                            8.2.6.3. Product/Service Benchmarking
                            8.2.6.4. Strategic Initiatives
                        8.2.7. Terumo Corporation
                            8.2.7.1. Company Overview
                            8.2.7.2. Financial Performance
                            8.2.7.3. Product/Service Benchmarking
                            8.2.7.4. Strategic Initiatives
                        8.2.8. Siemens Healthineers AG
                            8.2.8.1. Company Overview
                            8.2.8.2. Financial Performance
                            8.2.8.3. Product/Service Benchmarking
                            8.2.8.4. Strategic Initiatives
                        8.2.9. Baxter International Inc.
                            8.2.9.1. Company Overview
                            8.2.9.2. Financial Performance
                            8.2.9.3. Product/Service Benchmarking
                            8.2.9.4. Strategic Initiatives
                        8.2.10. Becton, Dickinson and Company
                            8.2.10.1. Company Overview
                            8.2.10.2. Financial Performance
                            8.2.10.3. Product/Service Benchmarking
                            8.2.10.4. Strategic Initiatives
                        8.2.11. B. Braun
                            8.2.11.1. Company Overview
                            8.2.11.2. Financial Performance
                            8.2.11.3. Product/Service Benchmarking
                            8.2.11.4. Strategic Initiatives
                        8.2.12. GE Healthcare
                            8.2.12.1. Company Overview
                            8.2.12.2. Financial Performance
                            8.2.12.3. Product/Service Benchmarking
                            8.2.12.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. interventional oncology procedures market, by technique, 2021 - 2033 (USD Billion)
Table 4 U.S. interventional oncology procedures market, by procedure, 2021 - 2033 (USD Billion)
Table 5 U.S. interventional oncology procedures market, by cancer type, 2021 - 2033 (USD Billion)
Table 6 U.S. interventional oncology procedures market, by end use, 2021 - 2033 (USD Billion)

List of Figures

Fig. 1 U.S. interventional oncology procedures market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Technique & procedure outlook (USD Billion)
Fig. 10 Camcer type & end use outlook (USD Billion)
Fig. 11 Competitive landscape
Fig. 12 U.S. interventional oncology procedures market dynamics
Fig. 13 U.S. interventional oncology procedures market: Porter’s five forces analysis
Fig. 14 U.S. interventional oncology procedures market: PESTLE analysis
Fig. 15 U.S. interventional oncology procedures market: Technique segment dashboard
Fig. 16 U.S. interventional oncology procedures market: Technique market share analysis, 2025 & 2033
Fig. 17 Ablation therapies market, 2021 - 2033 (USD Billion)
Fig. 18 Embolization therapies market, 2021 - 2033 (USD Billion)
Fig. 19 Biopsy techniques market, 2021 - 2033 (USD Billion)
Fig. 20 Targeted therapy Delivery Systems market, 2021 - 2033 (USD Billion)
Fig. 21 Image-guided procedures market, 2021 - 2033 (USD Billion)
Fig. 22 U.S. interventional oncology procedures market: Procedure segment dashboard
Fig. 23 U.S. interventional oncology procedures market: Procedure market share analysis, 2025 & 2033
Fig. 24 Tumor ablation market, 2021 - 2033 (USD Billion)
Fig. 25 Tumor biopsy market, 2021 - 2033 (USD Billion)
Fig. 26 Vascular interventions market, 2021 - 2033 (USD Billion)
Fig. 27 Palliative care market, 2021 - 2033 (USD Billion)
Fig. 28 U.S. interventional oncology procedures market: Cancer type segment dashboard
Fig. 29 U.S. interventional oncology procedures market: Cancer type market share analysis, 2025 & 2033
Fig. 30 Liver Cancer market, 2021 - 2033 (USD Billion)
Fig. 31 Lung Cancer market, 2021 - 2033 (USD Billion)
Fig. 32 Kidney market, 2021 - 2033 (USD Billion)
Fig. 33 Prostate cancer market, 2021 - 2033 (USD Billion)
Fig. 34 Others market, 2021 - 2033 (USD Billion)
Fig. 35 U.S. interventional oncology procedures market: End use segment dashboard
Fig. 36 U.S. interventional oncology procedures market: End use market share analysis, 2025 & 2033
Fig. 37 Hospitals market, 2021 - 2033 (USD Billion)
Fig. 38 Ambulatory surgical centers market, 2021 - 2033 (USD Billion)
Fig. 39 Others market, 2021 - 2033 (USD Billion)
Fig. 40 Company categorization
Fig. 41 Company market position analysis
Fig. 42 Strategic framework